Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Kelly Chenlei Li, MBBS, FRACP
Paul Bennett, RN, MHSM, PhD, FISN
Thilo Krüger, MD, PhD
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Jürgen Floege, MD
Uyen Huynh-Do, MD
Khalil El Karoui, MD
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes
Annette Bruchfeld, MD, PhD
Andreas Kronbichler, MD
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, DMSc, MD
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Incorporación de terapias dirigidas en la planificación del tratamiento de la VAA
David Jayne, MD
Bernhard Hellmich, MD
Almost Like Being There: Updates in IgA Nephropathy From Kidney Week
Howard Trachtman, MD, FASN
Hiddo L. Heerspink, PhD
Why We Should Be PRO Patients With CKD-Associated Pruritus
Lucio Manenti, MD, PhD
Jeanette Finderup, PhD, MHR, RN
Sebastian Koball, MD
Exploring Developments in IgAN and FSGS
Richard Lafayette, MD, FACP
PROTECT Study in IgAN: Topline Data
Jonathan Barratt, MD
The CKD Patient: Thinking Beyond the Numbers and Dialysis
Loreto Gesualdo, MD, FERA
George L. Bakris, MD, FAHA, FASN
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Incorporating Targeted Therapies in Treatment Planning for AAV
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Steven Fishbane, MD
Separating Fact from Fiction: The Realities of CKD-aP
Antoine Lanot, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.